​About The Hive 

The Hive, in association with the StartUp Health Network – now in its second year – is an immersive and informal social environment, dedicated to exploring and showcasing transformative startups and the inspiring entrepreneurs that power the ideas shaping the future of health and medicine.

At TEDMED 2014, we’ll invite a hand selected set of diverse innovators and entrepreneurs who represent transformative new companies across the innovation landscape in health and medicine to be a part of the TEDMED community and join us in Washington, DC or the San Francisco Bay Area. Their ideas and varied approaches will represent game-changing innovations coming out of incubators and accelerators, government-run challenges, academically led programs, independent startups and labs run by Fortune 500 companies across all areas of health and medicine.

With our Partners and Entrepreneurs at the heart of the Hive, the TEDMED delegation will be exposed to the leaders of today and the future leaders of tomorrow in a showcase of new approaches to innovation and scalable new ideas – celebrating the new possibilities that emerge from our collective or “hive” mind.

 
The Hive 2015Make a Nomination

Curators Reviewing Applications to The Hive

We received hundreds of applications for The Hive 2014. Currently, our team of thought-leaders and disruptive entrepreneurs are leading the charge in hand selecting this year's Hive startups. 

Meet the Curation Team


TEDMED Hive Application and Participation Guidelines 
 

Nominate a Startup

To help support a growing community of Hive entrepreneurs, we’re re-opening the Hive Application process for 2 short weeks, closing on April 1st, 2014.

We will be reviewing applications on an ongoing basis and will make all decisions no later than April 15th.

Before applying, it is important to ensure you are able to participate fully starting Tuesday, September 9th through Friday, September 12th. 

Participation: If you are selected to participate in The Hive 2014, you will attend under an “Innovation Scholarship,” which fully covers the $4,950 fee for attending TEDMED. This admission includes all TEDMED-hosted meals, snacks and events and includes the opportunity to create an experience to share your product or idea and to participate in the full TEDMED event, either in Washington, DC, or in San Francisco, CA. We will select The Hive location (San Francisco, CA and Washington, DC) as part of our review process, with the goal of providing a balanced variety of Hive startups in each location.

The Hive Startups are expected to cover all other costs, including hotel, transportation, shipping of materials, etc. 

What to expect: This is not a trade show, exhibit hall or demo day. The Hive is the central destination of TEDMED 2014’s social experience and is the primary networking location for the 1600 leaders and innovators that attend this invitation-only event. Your participation is not about a “pitch” but rather integrating you and your idea directly into the TEDMED ethos of multi-disciplinary discussion and exploration around innovation. 

Leadership: Representation of your idea will require participation from your senior leadership. Please note your admission badge is non-transferrable. To ensure necessary coverage and participation across the full days at TEDMED, the Scholarship will cover two individual leaders from your organization.  

Commitment: The Hive 2014 will require your onsite participation for a full four days in one of the two locations. As you will be attending on scholarship, you’ll have the full delegate experience: participation in all TEDMED activities, all 9 sessions, and all TEDMED evening events. The schedule in The Hive is as follows:

Tuesday, September 9th from 7am – 7pm
Wednesday, September 10th from 7am – 7pm
Thursday, September 11th from 7am – 7pm
Friday, September 12th from 7am – 5pm

Selection Process: TEDMED and a team of curators, each representing a different approach to innovation, will award all scholarships.

Space: As an important part of The Hive, you and your innovation will have a dedicated space within one of our social spaces located at the venues in Washington, DC and San Francisco, CA, where you can showcase your idea and/or approach to innovation. TEDMED is integrating The Hive startups into the larger TEDMED experience. Each startup will be asked to create an experience that shares the value or the “gift” their idea contributes to creating a better future for health and medicine.

Your experience does not translate directly to a “demo” – in fact the best experiences engage the Delegation directly with the problem, benefit or solution their idea addresses. TEDMED will work with each startup to help shape and guide an appropriate experience. TEDMED will provide structural support (i.e. electricity, flat screen monitors, tables, chairs, signage), the details of which will be available closer to the event. You will be responsible for manning your space, providing your physical product (if applicable) and all related content (digital and physical) enabling you to tell your story, share your idea and contribute to the larger conversation.

 

Continue to Application


Please note: If you are looking to apply for an invitation to attend TEDMED 2014 as a Delegate, please use our Delegate application process, as this application process is for participation and inclusion in The Hive only.

Hive 2013 Curation Team

Click to see bio
MichaelBlum.jpg
Michael Blum
Associate Vice Chancellor for Informatics; Chief Medical Information Officer; Director, Center for Digital Health Innovation
MichaelBlum.jpg

Dr. Michael Blum is the Associate Vice Chancellor for Informatics and a Professor of Medicine in Cardiology at the University of California, San Francisco. Dr. Blum is responsible for the strategic design and implementation of enterprise clinical and research information systems and technologies across UCSF.  Serving concurrently as UCSF’s Chief Medical Information Officer, he provides clinical leadership for the enterprise-wide implementation and optimization of Epic’s electronic health record as well as enterprise data warehousing.  Dr. Blum is an active clinician, specializing in general and preventative cardiology as well as the care of patients with congestive heart failure and valvular heart disease. Dr. Blum is passionate about wellness and the prevention of heart disease through a heart-healthy lifestyle. 

In his role as the Associate Vice Chancellor for Informatics, Dr. Blum also leads UCSF’s new Center for Digital Health Innovation (CDHI). The CDHI is a public-private partnership between UCSF and industry that incubates, validates, and commercializes novel digital technologies.  The CDHI develops internal and external digital health innovations through the proof of concept and pilot phases, validates them in real-world clinical settings, and partners with industry to build the technologies to scale and commercialize them.  The CDHI also provides a resource center to UCSF faculty and trainees, educating them in the technical, business, and intellectual property issues involved with developing and commercializing digital technologies.  

Prior to his medical career, Dr. Blum received his BS in Engineering at Tufts University. He then went on to receive his medical degree from NYU School of Medicine and completed his Internal Medicine residency and Cardiology felllowship at Yale University.  He now leverages his medical and engineering backgrounds as he applies his expertise in technology to health care, employing digital technologies to improve clinical effectiveness, efficiency, quality of care, and patient engagement and to develop new, clinically integrated care models, all in pursuit of Precision Medicine.  

Dr. Blum has been an advisor to numerous healthcare technology start-ups, early stage companies, and industry stalwarts.  He was the clinical lead on the joint Intel-Motion Computing development of the first successful healthcare-specific tablet computer, the Motion C5. Dr. Blum’s input is frequently sought by individuals and companies developing IT products in the EHR, cardiology, collaboration, monitoring, sensor, and mobility spaces. He serves on the board of the Association of Medical Directors for Information Systems and the Physician Leadership Committee of HIMSS. He is a frequent speaker at industry conferences and was recently invited to the White House to collaborate with CMS and ONC on the Blue Button Plus initiative and the administration’s plans to increase patient engagement and use of digital health information. When not working to improve the intersection of technology and healthcare, he can be found on the baseball diamond coaching his sons’ Little League team.

Michael Blum
Associate Vice Chancellor for Informatics; Chief Medical Information Officer; Director, Center for Digital Health Innovation
SumbulDesai.jpg
Sumbul Desai
Associate Chief Medical Officer,
Strategy and Innovation,
Stanford Medicine
SumbulDesai.jpg
Sumbul Ahmad Desai, MD currently serves as Associate Chief Medical Officer, Strategy and Innovation at Stanford Hospital and Clinics (SHC) where she is responsible for the product strategy, design and deployment of Stanford's virtual care and digital offerings. Dr. Desai also leads Stanford Hospital’s Strategy and Innovation group which is responsible for organizational strategy and development of Stanford Hospital and Clinics’ innovation efforts.  In conjunction with this role Dr. Desai continues to serve on faculty as Clinical Assistant Professor with Stanford University's School of Medicine (SOM) in the Department of Medicine. 

Dr. Desai speaks regularly on Innovation in Healthcare and is quickly becoming a leader in the space. Along with her work at the hospital, Dr. Desai is also focused on developing a research program that focuses on how to leverage technology to improve patient experience and coordination of care. She focuses on how both patients and providers think about the integration of technology into healthcare and how these advances will impact our lives.

Prior to entering the medical field, Dr. Desai spent the first several years of her career at The Walt Disney Company in Strategy and Business Development. She began her tenure at Disney on the editorial side at ABC News and then moved into a business leadership role in Strategy focused on the Studio business. 
Sumbul Desai
Associate Chief Medical Officer,
Strategy and Innovation,
Stanford Medicine
MohitKaushal.jpg
Mohit Kaushal
Partner, Aberdare Ventures
MohitKaushal.jpg
Mohit Kaushal is the newest member of the Aberdare team, joining as a partner in 2013.

Mohit has had an extensive career within clinical medicine, venture capital and health policy. He was most recently the inaugural Chief Strategy Officer and Executive Vice President of Business Development at West Health a unique set of entities focused on lowering health care costs through medical research, healthcare policy and investment. He developed the West Health Investment Fund strategy, sourced and led investments in Humedica (acquired by Optum Health), Change Healthcare, RxAnte and goBalto.

Previously, Mohit was the Director of Connected Health with the Federal Communications Commission, where he established the agency's first dedicated health care team. During his time in the Obama administration, he was also a member of the White House Health IT task force, a cross agency team focusing on implementing the technology aspects of Health Reform. Prior to this position, Kaushal was an investment professional at Polaris Venture Partners, and worked for Merrill Lynch's Health Care Investment Banking Group and the World Health Organization. Kaushal holds an MBA from Stanford and an MD with distinction from Imperial College, London.

In addition to his role at Aberdare Ventures, Mohit is an Adjunct Assistant Professor of Emergency Medicine at George Washington University and serves on the curation team at TEDMED. He has been appointed to the Consumer Technology Workgroup of the Health IT Standards Committee and to the National Committee on Vital and Health Statistics advising HHS on Data Access and Use.
Mohit Kaushal
Partner, Aberdare Ventures
Leslie-Bottorff.jpg
Leslie Bottorff
Managing Director
GE Ventures


Leslie-Bottorff.jpg
Leslie invests in start-up companies in the healthcare industry, specializing in MedTech and emerging business models.  Leslie comes to GE with 15 years of venture capital investing experience as managing director with ONSET Ventures.  Previous investments and board seats include Sadra Medical (sold to Boston Scientific), Spinal Concepts (sold to Abbott Labs), Neuronetics, Relievant, and VisionCare Ophthalmic.  Prior to venture investing, Leslie spent 19 years serving in various operating roles at both large and venture backed companies including VP Sales and Marketing of Medtronic's CardioRhythm division, VP Marketing of Embolic Protection, and other positions at Nellcor (now Covidien), Ventritex  (now St. Jude), Menlo Care (acquired by J & J), and GE's Medical Systems Division.  She holds a Bachelor's degree in biomedical engineering from Purdue University, and an MBA from Harvard Business School.  Leslie has served on advisory boards or as guest faculty at several universities including Purdue, Stanford, and UC Berkeley.
Leslie Bottorff
Managing Director
GE Ventures


drazan_ken_001_bertram_edit.jpg
Ken Drazan
Head, Johnson & Johnson
Innovation Center, California

drazan_ken_001_bertram_edit.jpg
Ken works with the California IC Team and partners with the other ICs in Boston, London (and soon Shanghai) and the R&D, business development, and business leaders across sectors to continue identifying, shaping and on-boarding the most promising science and technology opportunities at universities, academic centers, tech- and biotech companies, with the goal of catalyzing early stage innovation and bringing transformative medicines, devices, and consumer products to Johnson & Johnson.    
 
Ken brings a unique combination of skills and expertise to this role.  A liver transplant surgeon by training, Ken spent several years at Stanford University before moving into entrepreneurial leadership roles in the biopharmaceutical industry and subsequently in the venture capital world. Ken’s deep expertise in science, his business experience, and his strong ties to the Bay Area life science community position him well to lead our California IC.  
 
Ken joined  Johnson & Johnson on March 3. He comes from Bertram Capital Management which he co-founded in 2006. He served as General Partner of this family of growth equity funds focused on middle market equity investments in business services, consumer products, light manufacturing, and healthcare services. He was also Co-Founder and Chairman of EnGen Bio, a virtual company focused on a novel strain of flu vaccines.  Ken has held a variety of entrepreneurial leadership positions, including Founder, Chief Executive Officer, and Director of Arginox, a venture-backed company developing nitric oxide targeted medicines for critical care.    He also held the position of Vice President, Biology of Genesoft Pharmaceuticals, Inc., a company that developed anti-infective therapeutics in collaboration with the Department of Defense and for consumer markets.  
 
Prior to this, Ken worked as assistant professor of surgery at Stanford University School of Medicine where he directed the adult liver transplantation service at Stanford Hospital and coordinated an administrative staff of 15 people.  In this role, he was principal surgeon and coordinator of care of adult services (medical, nursing, clinical trials) before and after organ replacement. 
 
Ken earned his B.A. in Economics from Yale College and his received his M.D. Cum Laude from State University of New York.   He completed his residency and Postdoctoral Fellow at UCLA Medical Center, with a focus on surgery and microbiology.  
Ken Drazan
Head, Johnson & Johnson
Innovation Center, California

Regiskelley.jpg
Regis Kelly
Director, California Institute for Quantitative Biosciences (QB3) Professor, Dept. of Biochemistry & Biophysics, UCSF
Regiskelley.jpg
Dr. Regis B. Kelly is the Director of one of four California Institutes for Science and Innovation, created by the California Legislature to strengthen the academic foundation of its technology-based industries. QB3 is the only one of the four devoted exclusively to biology and to the life science industries. It is an innovation center made up of over 200 quantitative biologists at three northern California campuses (UCB, UCSC & UCSF) converting its discoveries into practical benefits for society.

From 2000 to 2004, Dr. Kelly served as Executive Vice Chancellor at the University of California in San Francisco, where his major responsibility was the new Mission Bay campus. This campus is the center of academic planning for a 300 acre public/private biomedical research park in San Francisco.

From 1995 to 2000, Dr. Kelly served as Chair of the Department of Biochemistry and Biophysics at UCSF; from 1988 to 1995, he was the Director of UCSF’s Cell Biology Graduate Program; and from 1992 to 2000, he was the Director of the Hormone Research Institute at UCSF. He has published extensively in the areas of cell and neurobiology and remains a Professor Emeritus of the Department of Biochemistry and Biophysics.

Dr. Kelly received his undergraduate degree in Physics from the University of Edinburgh in Scotland in 1961 and his Ph.D. in Biophysics from the California Institute of Technology in 1967. Following a post-doctoral fellowship at Stanford, Dr. Kelly was an instructor in the Department of Neurobiology at Harvard. He is Chairman Emeritus of the Bay Area Scientific Innovation Consortium (BASIC), is on the Malaysian Prime Minister’s Biotechnology Advisory Panel, and is on the Boards of the Scleroderma Foundation, and the San Francisco Mayor’s Biotechnology Advisory Group, the ChinaSF Program, among others. He is also a General Partner of Mission Bay Capital venture fund.

In 2011, Dr. Kelly was inducted into the Bay Area Business Hall. He has also received other awards for his support of entrepreneurship. He is a fellow of the American Academy of Arts and Sciences.
Regis Kelly
Director, California Institute for Quantitative Biosciences (QB3) Professor, Dept. of Biochemistry & Biophysics, UCSF
ShankarChandran.jpg
Shankar Chandran
Vice President
Samsung Catalyst Fund


ShankarChandran.jpg
Shankar Chandran is vice president, Samsung Catalyst Fund, at the Samsung Strategy and Innovation Center (SSIC). The SSIC is based in Menlo Park, California and is focused on accelerating innovation for Samsung Electronics. Shankar is responsible for early stage and disruptive venture capital investments in technologies targeted at high growth sectors such as cloud infrastructure, mobile technology and security, mHealth, next-generation user interfaces, and the internet of things. Previously, he was part of the founding team at Panorama Capital and has been an active venture investor for 12 years at Panorama Capital and JP Morgan Partners.

Shankar has held various engineering, business development and management roles at Applied Materials, Inc., and has been granted eight patents as the primary inventor. He also serves on the Advisory Board at the Center for Innovation and Entrepreneurship, Santa Clara University, and has served as a director or observer on the boards of over ten companies. 

Shankar holds a Bachelor of Technology degree in Metallurgical Engineering from the Indian Institute of Technology, India, an MS in Materials Science from Arizona State University, and an MBA from The Wharton School at the University of Pennsylvania.
Shankar Chandran
Vice President
Samsung Catalyst Fund


ThomasGoetz.jpg
Thomas Goetz
Co-Founder/CEO, Iodine and EIR, Robert Wood Johnson Foundation

ThomasGoetz.jpg
Thomas Goetz is an entrepreneur in residence at the Robert Wood Johnson Foundation, cofounder of Iodine, and the founder of 1+1 Labs, an information-design firm. He is author of, "The Decision Tree," and was a TEDMED speaker in 2010.
Thomas Goetz
Co-Founder/CEO, Iodine and EIR, Robert Wood Johnson Foundation

ZenChu.jpg
Zen Chu
Founder, Accelerated Medical Ventures | EIR for Martin Trust Center for MIT Entrepreneurship | Founder H@ckingMedicine @ MIT
ZenChu.jpg
Zen Chu believes that engineers will create the data, systems and products to help medicine scale to serve more patients with higher quality at lower cost. He runs Accelerated Medical Ventures, serving as cofounder and first investor for a few medical and software companies. As Healthcare Entrepreneur-In-Residence at MIT, Zen co-directs MIT/HST's Healthcare Ventures graduate course and oversees its HackingMedicine initiatives.

Alongside four world-renowned MIT biomaterials professors, Zen co-founded and served as CEO for 3D-Matrix Medical Inc., a venture-backed MIT regenerative medicine company with a successful IPO in 2011 and products helping patients. He has managed and led new ventures for Harvard Medical School, Wyss Institute, NetVentures and Hewlett-Packard.

Zen earned a BS in biomedical/electrical engineering from SMU and a Masters of Public & Private Management from Yale University. He's married to a serial software entrepreneur and they are raising three aspiring entrepreneurs.
Zen Chu
Founder, Accelerated Medical Ventures | EIR for Martin Trust Center for MIT Entrepreneurship | Founder H@ckingMedicine @ MIT
SeanHughes.jpg
Sean Hughes
Chief Design Officer,
Philips Healthcare | Vice President, Philips Design
SeanHughes.jpg
Sean Hughes, Chief Design Officer Philips Healthcare leads the global design team, developing a broad range of word class products, interfaces and consulting solutions, which are shaping the future of healthcare and saving lives. 

Over a 20+ year career across 3 continents and multiple business categories Sean has built and led multidisciplinary award winning design teams that deliver business results whilst maximizing role of design as a key element of sustainable competitive advantage.
Sean Hughes
Chief Design Officer,
Philips Healthcare | Vice President, Philips Design

Hive 2013 Curation Team

Click to see bio
lesa_mitchell.jpg
Lesa Mitchell
Vice President of Innovation and Networks
lesa_mitchell.jpg
Lesa Mitchell is vice president of Innovation and Networks at the Ewing Marion Kauffman Foundation. Her responsibilities include identification of programmatic and policy levers that can accelerate innovation and support networks enabling firm growth. Mitchell was instrumental in the founding of the Kauffman Innovation Network/iBridge Network, the Translational Medicine Conferences in the United States and Europe, and the National Academies-based University–Industry Partnership. She also is a leader in the replication of innovator-based commercialization and mentor programs across the United States. Mitchell is chairman of the Board of Kauffman FastTrac and serves on the Board of 8 Rivers Capital. She is an advisory board member of Modern Meadow Inc and the National Science Foundation iCorp. Prior to joining Kauffman, Mitchell spent twenty years of her career in global executive roles at Aventis and Quintiles, and as an entrepreneur focused on global management of electronic clinical trials.
Lesa Mitchell
Vice President of Innovation and Networks
SaraHoloubek.jpg
Sara Holoubek
CEO and founder of Luminary Labs
SaraHoloubek.jpg
Sara Holoubek is the CEO and founder of Luminary Labs, a consultancy focused on operationalizing innovation. Her firm has helped numerous companies achieve relevancy and business outcome by applying new and agile approaches to people, process, and technology. Ms. Holoubek is also an active adviser and investor. She currently serves on the Pioneer Advisory Group for the Robert Wood Johnson Pioneer Fund, and is a formal adviser to private sector companies WMI, Clickable, Hoseanna, and Achievemint. Previously, Ms. Holoubek served as iCrossing's Chief Strategy Officer, building the firm's New York office and repositioning the iCrossing brand as it raised an early VC round of $13 million. Prior to this experience, Ms. Holoubek held strategy roles with interactive agencies Organic and Blue Dingo. From 2009-2010, Ms. Holoubek served as the President of SEMPO, the global trade marketing organization for the search marketing industry. She currently serves on the New York Board of Directors of the, Step Up Women's Network. In 2011, she was the recipient of the Pepsico WINaward for her contributions to the tech community, including the development of A Field Guide To, a list of high-profile female founders, deal-makers and influencers. Ms. Holoubek has been widely quoted in publications such as The Washington Post, WSJ.com, Adweek, Internet Retailer, Strategies (France) and PropMark (Brazil). She also serves as a frequent guest lecturer on the subjects of technology and innovation. Ms. Holoubek also brings an international perspective to her work, having lived and worked in Latin America and Europe; she is fluent in Spanish and French, and conversant in Portuguese. She holds a B.A. from the University of Iowa and an M.B.A. from HEC in France. She resides in New York City with her husband, bass-baritone Claudio Mascarenhas.
Sara Holoubek
CEO and founder of Luminary Labs
Jonah.jpg
Jonah Czerwinksi
Director, VA Center for Innovation
Jonah.jpg
Jonah J. Czerwinski is Senior Advisor to the Secretary of Veterans Affairs and leads the VA Center for Innovation (VACI). He assists the Secretary on a range of strategy and policy issues regarding VA budget, management, and transformation. He advises senior VA leadership in identifying, articulating, and disseminating strategic guidance and management priorities. As Director of VACI, he is responsible for designing and leading the program's implementation across VA. VACI identifies, prioritizes, funds, tests, and deploys the most promising solutions to VA's most important challenges. VACI taps the talent and expertise of individuals both inside and outside government by funding new, innovative solutions that increase Veterans' access to VA services, improve the quality of services delivered, enhance the performance of VA operations, and reduce or control the cost of delivering those services that Veterans and their families receive. Prior to joining VA, Mr. Czerwinski was Managing Consultant at IBM Global Business Services and was a Senior Fellow in IBM's Global Leadership Initiative. Jonah also served as a Senior Advisor for the Center for the Study of the Presidency, a Senior Fellow at the Homeland Security Policy Institute of the George Washington University, and a member of the Board of Directors at the Partnership for a Secure America. Before joining government, he served on the Task Force on Leveraging National Laboratory S&T Assets for 21st Century Security. He is the co-author of "Global Movement Management: Strengthening Commerce, Security, and Resiliency In Today's Networked World." Mr. Czerwinski graduated magna cum laude from Salve Regina University (A.B., Philosophy) and earned his M.B.A. from the University of Virginia Darden School of Business.
Jonah Czerwinksi
Director, VA Center for Innovation
GregDowning.jpg
Greg Downing
United States Department of Health and Human Services (HHS)
GregDowning.jpg
Gregory Downing, D.O., Ph.D. is the Executive Director for Innovation in the Immediate Office of the Secretary at the United States Department of Health and Human Services (HHS). In this role he helps promote innovation and entrepreneurship activities across HHS. In addition, he supports open government activities through uses of technology and data to promote improvement in health and health care. Prior to his move to HHS in 2006, Dr. Downing served at the National Institutes of Health since 1993 in research, policy, and program management roles. Dr. Downing earned his medical degree from Michigan State University and his Ph.D. in pharmacology from the University of Kansas.
Greg Downing
United States Department of Health and Human Services (HHS)
CharlesHuang.jpg
Charles Huang
VP at Equity Health LLC, Blackstone Group
CharlesHuang.jpg
Charles Huang is a Vice President and the Chief Finance and Financial Analysis Officer of Equity Healthcare, within Blackstone’s Private Equity Operations Group. Prior to joining Blackstone in 2012, Mr. Huang worked in venture capital, focusing on health technology investing and actively supporting healthcare portfolio companies of Spark Capital. Prior to Spark Capital, while completing a dual Master’s degree program in Business and Public Administration, he helped contribute to the growth of a number of VC/PE-backed healthcare companies in the areas of strategy, operations, and clinical informatics/reporting, including Generation Health and Accelecare Wound Centers. Before graduate school, Charles was a Manager in the Strategic Financial Planning Group at Harvard Pilgrim Health Care and had also worked previously in the health consulting practice at Towers Perrin. Mr. Huang has co-authored several Harvard Business School cases and notes on healthcare innovation, payment, and policy. In addition to his M.B.A. and M.P.A. from Harvard, Mr. Huang holds a B.A. in Public Health from Johns Hopkins University.
Charles Huang
VP at Equity Health LLC, Blackstone Group
scott_case.jpg
Scott Case
CEO of the Startup America Partnership
scott_case.jpg
Timothy "Scott" Case (not related to Steve Case) is a technologist, entrepreneur and inventor and was founding CTO of Priceline, the "Name Your Own Price" company that was one of only a handful of startups in U.S. history to reach a billion dollars in annual sales in less than 24 months. As Chief Technology Officer, he was responsible for building the technology that enabled Priceline’s hyper-growth. Most recently, Scott was named CEO and board member of the Startup America Partnership, where he’ll invest his energy to drive American entrepreneurship to create jobs and sustain our nation's global leadership. Prior to joining the Startup America Partnership, Scott served as CEO of Malaria No More, where he worked to inspire individuals and institutions in the private sector to end deaths caused by malaria. Previously, Scott helped build a portfolio of intellectual property at the Walker Digital Invention Laboratory, and is a named inventor on dozens of U.S. patents including the underlying portfolio for Priceline. Scott also co-founded Precision Training Software, a software company that developed the world's first PC-based simulated flight instructor and photo-realistic flight simulator. Scott serves as the Chairman of Network for Good, a national nonprofit that has distributed more than $475 million to 60,000 nonprofits and provides online fundraising and communications services to over 5,000 nonprofit organizations. He is also on the Advisory Board of By Kids for Kids, Tickets-for-Charity and ThreeJars.
Scott Case
CEO of the Startup America Partnership
LisaKennedy.jpg
Lisa Kennedy
Chief Marketing Officer, GE healthymagination
LisaKennedy.jpg
Lisa Kennedy, PH.D. is Chief Marketing Officer for GE’s healthymagination initiative, a $6 billion commitment to improving quality, access, and affordability with the goal of revolutionizing the world’s healthcare. The collaboration relies heavily on technology, people, and partnerships to identify and develop ideas, such as an open innovation challenge in cancer to identify new areas to accelerate innovation and access to cancer care. Her team also leads digital health incubation focusing on patient empowerment and ambient intelligence. Dr. Kennedy joined GE Healthcare as Chief Economist before becoming Global Head of Marketing Operations, GEHC, where she was an integral part of the team that created healthymagination. She earned her Ph.D. in economics from the University of St Andrews in Scotland.
Lisa Kennedy
Chief Marketing Officer, GE healthymagination